TWiV 828: COVID-19 clinical update #88 with Dr. Daniel Griffin

<div class="entry-content"> <p>In COVID-19 clinical update #88, Dr. Griffin covers vaccine protection among US veterans, absence of long COVID in vaccinated who are infected, single dose of REGEN-COV monoclonal antibody cocktail provides long term protection, and Pfizer protease inhibitor Paxlovid is 89% effective in preventing hospitalization or death.</p> <p>Hosts: <a href="http://parasiteswithoutborders.com/">Daniel Griffin</a> and <a href= "http://en.wikipedia.org/wiki/Vincent_Racaniello">Vincent Racaniello</a></p> <p>Subscribe (free): <a href= "http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784">iTunes</a>, <a href="https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D">Google Podcasts</a>, <a href= "http://twiv.microbeworld.libsynpro.com/twiv">RSS</a>, <a href="http://eepurl.com/Gcw59">email</a></p> <p>Become a <a href= "https://www.microbe.tv/contribute">patron</a> of TWiV!</p> <h3><strong>Links for this episode</strong></h3> <ul> <li><a href= "https://www.science.org/doi/10.1126/science.abm0620">Vaccine protection</a> of US veterans (Science)</li> <li><a href= "https://investor.regeneron.com/news-releases/news-release-details/new-phase-3-analyses-show-single-dose-regen-covr-casirivimab-and?fbclid=IwAR1TZORVBtQbbATQ-_wUytFBPt8Ah_XJo5qsyWcRT9foKwTZN3dFJh1wAYI"> Long term protection</a> by REGEN-COV (Regeneron)</li> <li>Pfizer <a href= "https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate"> protease inhibitor Paxlovid</a> phase 2/3 results (Pfizer)</li> <li><a href="https://www.microbe.tv/twiv/twiv-828-letters/">Letters read</a> on TWiV 828</li> <li>Timestamps by <a href= "http://www.twitter.com/jrrmicro">Jolene</a>. Thanks!</li> </ul> <p>Intro music is by <a href= "http://www.ronaldjenkees.com/">Ronald Jenkees</a><br /> <br /> Send your questions for Dr. Griffin to daniel@microbe.tv</p> </div>